Prasad’s short FDA tenure brought stricter review standards for gene and COVID vaccines, sparking biotech concern and political backlash.

Other changes under Prasad, who was also the agency's chief medical and science officer, included a new policy limiting the ...

Vinay Prasad's interim replacement has concerns about same drug that drove him out. NIH director says employee critics ...

The former official, Vinay Prasad, had been on the job three months and had recently come under attack by conservative ...

The U.S. Food and Drug Administration's top vaccine official, Vinay Prasad, has left the agency after just three months as ...

Since taking office, President Donald Trump has brusquely removed a number of top officials from their positions, including a ...

A spokesperson for the Department of Health and Human Services confirmed that Dr. Vinay Prasad, who led the FDA’s Center for ...

OH and the leaf of the kratom plant are not analogous, but as the former is a derivative of the latter, it has opioid-like qualities that make its susceptibility to abuse concerning.

Evidence-based medicine "Boy Wonder" Dr. Vinay Prasad was fired as CBER Director after less than three months on the job.

Analysts say the departure of the CBER head may alleviate overhang in the cell and gene therapy space. Vinay Prasad, head of the Center for Biologics Evaluation and Research (CBER) at the US Food and ...

Dr. Vinay Prasad had been serving as the FDA's director of the Center for Biologics Evaluation and Research since May, and ...

The motivation is solely what we think is in the public interest— the accurate judgment of benefits and risks,” Prasad wrote.